, Singapore

Australia's BlueChilli teams up with Enterprise Singapore to launch healthtech accelerator programme

Select startups will get access to tech development services and seed funding.

Australian venture studio and innovation group BlueChilli has partnered with Enterprise Singapore to launch a Singapore-based healthtech accelerator, an announcement revealed.

The BlueChilli healthtech accelerator will reportedly scout for ideas from domain experts across Southeast Asia, and founders who will be selected to build or advance their startup through the programme will get access to tech development services with no additional cost, startup training, seed funding and a global network of advisors and mentors.

The Asia Pacific’s healthtech sector is said to be the second largest in the world for investment funds raised, after only the US. In 2018, $8.59b (US$6.3b) was deployed into healthtech startups in the region, which significantly exceeded 2017 and doubled that of 2016. Southeast Asia’s healthtech ecosystem is still emerging within the region and poised for growth, with Singapore and Indonesia contributing to most of its notable deals in 2018.

Also read: Here's why Singapore's healthtech landscape looks promising

“New ideas, innovative business models and emerging technologies coming out of the accelerator have immense potential to disrupt and transform the health industry and improve quality of life across the globe,” according to BlueChilli’s CEO Sebastien Eckersley-Maslin . “By removing the barriers of access to technology and capital, we can help a more diverse range of entrepreneurs in Southeast Asia bring their unique experiences and novel ideas to the global innovation ecosystem.”

Building up its activities in the region, BlueChilli also launched an innovation centre in partnership with Coca-Cola Amatil in Indonesia in April 2019.

Meanwhile, BlueChilli has also joined Enterprise Singapore’s Startup SG Accelerator initiative with its healthtech accelerator programme.

Applications for the BlueChilli healthtech accelerator will open on 28 May. 

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.